Epilepsy, Antiepileptic Drugs and Lipid Mechanisms

dc.authoridTecellioglu, Mehmet/0000-0002-8381-9630
dc.authoridKamisli, Ozden/0000-0003-1114-7860
dc.authoridKamisli, Ozden/0000-0003-1114-7860
dc.authorwosidTecellioglu, Mehmet/AAA-3220-2021
dc.authorwosidKamisli, Ozden/JVZ-0145-2024
dc.authorwosidKamisli, Ozden/AAA-6553-2020
dc.contributor.authorKamisli, Ozden
dc.contributor.authorTecellioglu, Mehmet
dc.date.accessioned2024-08-04T20:58:40Z
dc.date.available2024-08-04T20:58:40Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractHigh levels of lipids and lipoproteins in young adults are significant risk factors for the development of heart disease in older ages. Increased levels of total cholesterol and triglycerides, high levels of low-density lipoprotein and low levels of high-density lipoprotein contribute to cardiovascular disease. Therefore, when starting antiepileptics, it is important to assess changes in serum lipid levels and choose the safety drug, thus contributing to the prevention of cardiovascular complications in older ages. This paper is a review of the e effects of AED use on plasma lipid parameters.en_US
dc.identifier.doi10.14744/epilepsi.2018.60590
dc.identifier.endpage69en_US
dc.identifier.issn1300-7157
dc.identifier.startpage66en_US
dc.identifier.urihttps://doi.org/10.14744/epilepsi.2018.60590
dc.identifier.urihttps://hdl.handle.net/11616/103073
dc.identifier.volume24en_US
dc.identifier.wosWOS:000438304900012en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherKare Publen_US
dc.relation.ispartofEpilepsien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAntiepileptic drugsen_US
dc.subjectepilepsyen_US
dc.subjectlipiden_US
dc.titleEpilepsy, Antiepileptic Drugs and Lipid Mechanismsen_US
dc.typeReview Articleen_US

Dosyalar